| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $5.3B | $4.8B | $-1.0B | $6.3B | $6.4B | $4.5B | $3.2B | $3.3B |
| EPS (Basic) | $3.87 | $3.36 | $-1.09 | $4.46 | $4.51 | $3.11 | $3.76 | $3.96 |
| EPS (Diluted) | $3.82 | $3.36 | $-1.09 | $4.43 | $4.47 | $3.08 | $3.71 | $3.91 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $547.5B | $531.2B | $535.3B | $555.3B | $541.2B | $509.2B | $473.1B | $225.7B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | $20.3B | $18.9B | $19.1B | $4.0B |
| Total Liabilities | $482.3B | $467.5B | $476.1B | $494.7B | $472.0B | $438.3B | $406.5B | $195.5B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $65.2B | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.7B | $2.2B | $8.6B | $11.1B | $7.9B | $7.4B | $1.5B | $4.3B |
| Investing Cash Flow | $-17.8B | $18.6B | $22.9B | $-30.0B | $-32.1B | $-43.7B | $8.3B | $-4.9B |
| Capital Expenditures | — | — | — | $0.6B | $0.4B | $0.8B | — | — |
| Financing Cash Flow | $8.6B | $-11.6B | $-22.3B | $20.0B | $25.6B | $36.0B | $5.4B | $1.5B |